Medication info
Clopiren Tablets (Clopidogrel Sulfate)

Clopiren Tablets (Clopidogrel Sulfate)

Prescription medicationTabletOral
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
HLB Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201309810 · Approved 2013.10.18 · Insurance code 647302700

Summary

Main use
Improvement of atherosclerotic symptoms; prevention of thromboembolism in atrial fibrillation
Who takes it
Adults
Adult dose
○ Adults 1. In patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer 75 mg of clopidogrel orally once daily. 2. In patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), initiate treatment on the first day with a loading dose of 300 mg of this drug once daily, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be administered concomitantly with this drug once daily. 3. In patients with atrial fibrillation, administer 75 mg of this drug orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this drug once daily. ○ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment: Treatment experience in patients with moderate hepatic disease and bleeding diathesis is limited. This drug may be administered with or without food.

Ingredients

Manufacturer
HLB Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of atherosclerotic symptoms; prevention of thromboembolism in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral arterial disease
  • acute coronary syndrome
  • unstable angina
  • non-Q-wave myocardial infarction
  • cardiovascular abnormalities
  • stroke
  • refractory ischemia
  • vascular risk factors
  • risk of bleeding
  • atrial fibrillation
View approved original text

This medication is used to improve symptoms caused by atherosclerosis in adult patients with ischemic stroke, myocardial infarction, or peripheral arterial disease. It also reduces the risk of cardiovascular events and improves symptoms in patients with acute coronary syndrome, namely unstable angina or non-Q-wave myocardial infarction, who have undergone medical treatment, percutaneous coronary intervention, or coronary artery bypass surgery. Additionally, it helps reduce the risk of stroke and thromboembolism in atrial fibrillation patients with vascular risk factors where vitamin K antagonists are not suitable. This medication is effectively used for thrombus prevention and symptom improvement in various cardiovascular diseases.

How to take

Adult dose

○ Adults 1. In patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer 75 mg of clopidogrel orally once daily. 2. In patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), initiate treatment on the first day with a loading dose of 300 mg of this drug once daily, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be administered concomitantly with this drug once daily. 3. In patients with atrial fibrillation, administer 75 mg of this drug orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this drug once daily. ○ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment: Treatment experience in patients with moderate hepatic disease and bleeding diathesis is limited. This drug may be administered with or without food.

Precautions

This medication is an antiplatelet agent that prevents blood platelets from aggregating to avoid thrombus formation. This medication may not be effective in individuals with genetically reduced function of a specific enzyme (CYP2C19), and in such cases, alternative treatments should be considered. Furthermore, taking this medication alongside drugs that activate specific enzymes can increase the concentration of the active ingredient, thereby raising the risk of bleeding, so concurrent use is not recommended. This medication should not be administered to patients with bleeding, severe liver impairment, individuals allergic to the drug's components, nursing women, and those with certain genetic diseases such as lactose intolerance. For patients at high risk of bleeding or suspected of having bleeding disorders, prompt blood tests should be performed, and it may be necessary to discontinue this medication 5 to 7 days prior to surgery. Caution is needed when this medication is taken together with other antiplatelet agents, anticoagulants, non-steroidal anti-inflammatory drugs, and certain antidepressants, as it can increase the risk of bleeding. During pregnancy, the effects on the fetus might not be significant; however, there may be an increased risk of bleeding during delivery, so discontinuation of the drug before labor is recommended. In nursing mothers, it is unclear whether this medication is secreted in breast milk, so careful consideration is needed to decide whether to continue breastfeeding or stop medication. Elderly patients or those with reduced kidney or liver function may have an increased risk of bleeding, thus requiring dose adjustments and monitoring of patient status. If easy bleeding occurs or bleeding does not stop during treatment, or if symptoms such as frequent bruising or rashes appear, medical consultation should be sought immediately. In case of overdose, bleeding time may be prolonged and bleeding complications may occur, in which case platelet transfusion can partially reverse the drug's effect. This medication is not recommended for use in children as its safety and efficacy have not been sufficiently verified. The medication should be stored out of reach of children, and care should be taken not to transfer it to other containers, as this may alter its quality.

Side effects

  • Hemorrhage
  • gastrointestinal hemorrhage
  • purpura
  • contusion
  • hematoma
  • epistaxis
  • hematoma
  • hematuria
  • intraocular hemorrhage
  • intracranial hemorrhage
Show 137 more
  • neutropenia
  • agranulocytosis
  • aplastic anemia
  • thrombocytopenia
  • abdominal pain
  • dyspepsia
  • diarrhea
  • nausea
  • rash
  • pruritus
  • chest pain
  • accidental injury
  • influenza-like illness
  • pain
  • fatigue
  • edema
  • hypertension
  • headache
  • dizziness
  • depression
  • upper respiratory tract infection
  • dyspnea
  • rhinitis
  • bronchitis
  • cough
  • urinary tract infection
  • decreased motor function
  • tremors
  • voice disorders
  • abnormal gait
  • hyperkinesis
  • ataxia
  • paresthesia
  • constipation
  • vomiting
  • ulcer
  • abdominal pain
  • loss of appetite
  • hiccups
  • thirst
  • dysphagia
  • tongue disorders
  • insomnia
  • depression
  • forgetfulness
  • anxiety
  • hyperesthesia
  • disorientation
  • abnormal behavior
  • rigidity
  • facial edema
  • syncope
  • purpura
  • melena
  • thrombocytopenia
  • anemia
  • pneumonia
  • sinusitis
  • visual disturbances
  • visual field defects
  • dry eye syndrome
  • temporary blindness
  • congestion
  • tinnitus
  • taste disturbance
  • urination disorders
  • polyuria
  • non-protein nitrogen increase
  • uremia
  • increased blood urea nitrogen
  • hypoglycemia
  • hyperuricemia
  • elevated liver enzymes
  • ALT elevation
  • liver function abnormality
  • leg edema
  • arrhythmia
  • bradycardia
  • palpitations
  • contact dermatitis
  • gynecomastia
  • elevated prostate-specific antigen
  • allergic symptoms
  • ischemic necrosis
  • gastritis
  • hemorrhagic gastroenteritis
  • duodenal ulcer
  • gastric ulcer
  • perforated gastric ulcer
  • upper gastrointestinal ulcer hemorrhage
  • distension
  • hyperbilirubinemia
  • infectious hepatitis
  • fatty liver
  • hemorrhagic arthropathy
  • hematuria
  • hemoptysis
  • retroperitoneal hemorrhage
  • surgical wound hemorrhage
  • pulmonary hemorrhage
  • serum sickness
  • confusion
  • hallucinations
  • taste anomalies
  • taste loss
  • vasculitis
  • hypotension
  • bronchospasm
  • interstitial pneumonia
  • eosinophilic pneumonia
  • colitis
  • pancreatitis
  • stomatitis
  • hepatitis
  • acute liver failure
  • herpes simplex
  • erythematous rash
  • maculopapular rash
  • urticaria
  • angioedema
  • vesicular dermatitis
  • drug-induced hypersensitivity syndrome
  • eosinophilia
  • drug rash
  • eczema
  • lichen planus
  • arthralgia
  • arthritis
  • myalgia
  • glomerular disease
  • gynecomastia
  • fever
  • abnormal liver function test results
  • increased blood creatinine
  • cholecystitis
  • hematemesis
  • spinal hematoma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture; therefore, it should be stored in a tightly sealed container. Avoid keeping it in extremely hot or cold places, and store it at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.